MIMT1 and melanoma: The present study is the first that shows the capacity of specific Mcl-1 protein inhibitor – MIM1 to induce apoptosis in the amelanotic melanoma cells with BRAF V600E mutation and to intensify the proapoptotic properties of DTIC.